Francesca Maria Carozzi

Summary

Affiliation: Centro per lo Studio e la Prevenzione Oncologica
Country: Italy

Publications

  1. ncbi Triage with human papillomavirus testing of women with cytologic abnormalities prompting referral for colposcopy assessment
    Francesca Maria Carozzi
    Analytical and Biomolecular Cytology Unit, Centro per lo Studio e la Prevenzionc Oncologica, Florence, Italy
    Cancer 105:2-7. 2005
  2. ncbi Conventional pap smear and liquid-based cervical cytology smear: comparison from the same patient
    Massimo Confortini
    Cytopathology Unit, Borgo San Lorenzo Hospital, Florence, Italy
    Tumori 88:288-90. 2002
  3. ncbi Combined analysis of HPV DNA and p16INK4a expression to predict prognosis in ASCUS and LSIL pap smears
    Francesca Maria Carozzi
    CSPO, Scientific Institute of Tuscany Region, Analytical Cytology and Biomolecular Unit, Florence, Italy
    Coll Antropol 31:103-6. 2007
  4. ncbi [Biological basis for HPV vaccines]
    Francesca Maria Carozzi
    UO Citologia analitica e molecolare, CSPO, Istituto scientifico prevenzione oncologica, Firenze
    Epidemiol Prev 31:92-9. 2007
  5. ncbi Agreement between the AMPLICOR Human Papillomavirus Test and the Hybrid Capture 2 assay in detection of high-risk human papillomavirus and diagnosis of biopsy-confirmed high-grade cervical disease
    Francesca Carozzi
    Centro per lo Studio e la Prevenzione Oncologica, Unità Operativa Citologia Analitica e Molecolare, Via Cosimo il Vecchio 2, 50127 Firenze, Italy
    J Clin Microbiol 45:364-9. 2007
  6. ncbi Molecular profile in body fluids in subjects enrolled in a randomised trial for lung cancer screening: Perspectives of integrated strategies for early diagnosis
    Francesca Maria Carozzi
    Analytical and Biomolecular Cytology Unit, ISPO Cancer Prevention and Research Institute, Via Cosimo il Vecchio 2, 50139 Florence, Italy
    Lung Cancer 68:216-21. 2010
  7. ncbi Is human papillomavirus screening preferable to current policies in vaccinated and unvaccinated women? A cost-effectiveness analysis
    Gabriele Accetta
    Biostatistics Unit, ISPO Cancer Research and Prevention Institute, Via Cosimo il Vecchio 2, 50139 Florence, Italy
    J Med Screen 17:181-9. 2010
  8. ncbi Reproducibility of HPV DNA Testing by Hybrid Capture 2 in a Screening Setting
    Francesca Maria Carozzi
    Center for Study and Prevention of Cancer (CSPO, Florence, Italy
    Am J Clin Pathol 124:716-21. 2005
  9. ncbi Prognostic significance of p53 and Ki-67 antigen expression in surgically treated non-small cell lung cancer: immunocytochemical detection with imprint cytology
    Cristina Maddau
    Cytopathology Unit, Center for Study and Cancer Prevention, Florence, Italy
    Am J Clin Pathol 125:425-31. 2006
  10. ncbi Design, recruitment and baseline results of the ITALUNG trial for lung cancer screening with low-dose CT
    Andrea Lopes Pegna
    Pneumology Department, Careggi Hospital, Florence, Italy
    Lung Cancer 64:34-40. 2009

Collaborators

Detail Information

Publications10

  1. ncbi Triage with human papillomavirus testing of women with cytologic abnormalities prompting referral for colposcopy assessment
    Francesca Maria Carozzi
    Analytical and Biomolecular Cytology Unit, Centro per lo Studio e la Prevenzionc Oncologica, Florence, Italy
    Cancer 105:2-7. 2005
    ..CONCLUSIONS: Because HPV testing is highly sensitive, it may be useful as an alternative to the current policy of 6-month repeat cytology for women with ASCUS...
  2. ncbi Conventional pap smear and liquid-based cervical cytology smear: comparison from the same patient
    Massimo Confortini
    Cytopathology Unit, Borgo San Lorenzo Hospital, Florence, Italy
    Tumori 88:288-90. 2002
    ..The results of blind reading of smears obtained with liquid-based cytology in patients previously screened by conventional cytology were compared...
  3. ncbi Combined analysis of HPV DNA and p16INK4a expression to predict prognosis in ASCUS and LSIL pap smears
    Francesca Maria Carozzi
    CSPO, Scientific Institute of Tuscany Region, Analytical Cytology and Biomolecular Unit, Florence, Italy
    Coll Antropol 31:103-6. 2007
    ..In conclusion, overexpression of p16INK4a acts as potential biomarkers for cervical cancer progression from premalignant lesions...
  4. ncbi [Biological basis for HPV vaccines]
    Francesca Maria Carozzi
    UO Citologia analitica e molecolare, CSPO, Istituto scientifico prevenzione oncologica, Firenze
    Epidemiol Prev 31:92-9. 2007
  5. ncbi Agreement between the AMPLICOR Human Papillomavirus Test and the Hybrid Capture 2 assay in detection of high-risk human papillomavirus and diagnosis of biopsy-confirmed high-grade cervical disease
    Francesca Carozzi
    Centro per lo Studio e la Prevenzione Oncologica, Unità Operativa Citologia Analitica e Molecolare, Via Cosimo il Vecchio 2, 50127 Firenze, Italy
    J Clin Microbiol 45:364-9. 2007
    ..7% of cases, while 21% of cases were negative. In conclusion, AMP provides a viable alternative to HC2, with good agreement for samples with high-grade cytology and similar sensitivity in detecting CIN2+ lesions...
  6. ncbi Molecular profile in body fluids in subjects enrolled in a randomised trial for lung cancer screening: Perspectives of integrated strategies for early diagnosis
    Francesca Maria Carozzi
    Analytical and Biomolecular Cytology Unit, ISPO Cancer Prevention and Research Institute, Via Cosimo il Vecchio 2, 50139 Florence, Italy
    Lung Cancer 68:216-21. 2010
    ..This study, embedded in an early diagnosis randomised trial, suggests that a multi-screening approach integrating imaging technique and a biomolecular marker panel is worth of further investigation...
  7. ncbi Is human papillomavirus screening preferable to current policies in vaccinated and unvaccinated women? A cost-effectiveness analysis
    Gabriele Accetta
    Biostatistics Unit, ISPO Cancer Research and Prevention Institute, Via Cosimo il Vecchio 2, 50139 Florence, Italy
    J Med Screen 17:181-9. 2010
    ..The introduction of new technologies such as HPV DNA testing and HPV vaccination requires cost-effectiveness analysis of cervical cancer strategies in Italy for both vaccinated and unvaccinated women...
  8. ncbi Reproducibility of HPV DNA Testing by Hybrid Capture 2 in a Screening Setting
    Francesca Maria Carozzi
    Center for Study and Prevention of Cancer (CSPO, Florence, Italy
    Am J Clin Pathol 124:716-21. 2005
    ..91, 0.60, and 0.69 with PreservCyt and 0.93, 0.87, and 0.90 with STM. Our data showed high reliability and reproducibility with HC2, with values higher for STM than ThinPrep (Cytyc) samples...
  9. ncbi Prognostic significance of p53 and Ki-67 antigen expression in surgically treated non-small cell lung cancer: immunocytochemical detection with imprint cytology
    Cristina Maddau
    Cytopathology Unit, Center for Study and Cancer Prevention, Florence, Italy
    Am J Clin Pathol 125:425-31. 2006
    ....
  10. ncbi Design, recruitment and baseline results of the ITALUNG trial for lung cancer screening with low-dose CT
    Andrea Lopes Pegna
    Pneumology Department, Careggi Hospital, Florence, Italy
    Lung Cancer 64:34-40. 2009
    ..We report design and results of enrolment and baseline screening test in the ITALUNG trial, a RCT...